Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1999 Feb;229(2):210–215. doi: 10.1097/00000658-199902000-00008

Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal.

O Farges 1, B Malassagne 1, J F Flejou 1, S Balzan 1, A Sauvanet 1, J Belghiti 1
PMCID: PMC1191633  PMID: 10024102

Abstract

OBJECTIVE: To explore the relation of patient age, status of liver parenchyma, presence of markers of active hepatitis, and blood loss to subsequent death and complications in patients undergoing a similar major hepatectomy for the same disease using a standardized technique. SUMMARY BACKGROUND DATA: Major liver resection carries a high risk of postoperative liver failure in patients with chronic liver disease. However, this underlying liver disease may comprise a wide range of pathologic changes that have, in the past, not been well defined. METHODS: The nontumorous liver of 55 patients undergoing a right hepatectomy for hepatocellular carcinoma was classified according to a semiquantitative grading of fibrosis. The authors analyzed the influence of this pathologic feature and of other preoperative variables on the risk of postoperative death and complications. RESULTS: Serum bilirubin and prothrombin time increased on postoperative day 1, and their speed of recovery was influenced by the severity of fibrosis. Incidence of death from liver failure was 32% in patients with grade 4 fibrosis (cirrhosis) and 0% in patients with grade 0 to 3 fibrosis. The preoperative serum aspartate transaminase (ASAT) level ranged from 68 to 207 IU/l in patients with cirrhosis who died, compared with 20 to 62 in patients with cirrhosis who survived. CONCLUSION: A major liver resection such as a right hepatectomy may be safely performed in patients with underlying liver disease, provided no additional risk factors are present. Patients with a preoperative increase in ASAT should undergo a liver biopsy to rule out the presence of grade 4 fibrosis, which should contraindicate this resection.

Full text

PDF
210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belghiti J., Marty J., Farges O. Techniques, hemodynamic monitoring, and indications for vascular clamping during liver resections. J Hepatobiliary Pancreat Surg. 1998;5(1):69–76. doi: 10.1007/pl00009953. [DOI] [PubMed] [Google Scholar]
  2. Belghiti J., Panis Y., Farges O., Benhamou J. P., Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991 Aug;214(2):114–117. doi: 10.1097/00000658-199108000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Capussotti L., Borgonovo G., Bouzari H., Smadja C., Grange D., Franco D. Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg. 1994 Mar;81(3):427–431. doi: 10.1002/bjs.1800810335. [DOI] [PubMed] [Google Scholar]
  4. Caselmann W. H., Alt M. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J Hepatol. 1996;24(2 Suppl):61–66. [PubMed] [Google Scholar]
  5. Fan S. T., Lai E. C., Lo C. M., Chu K. M., Liu C. L., Wong J. Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg. 1996 Jan;83(1):117–120. doi: 10.1002/bjs.1800830138. [DOI] [PubMed] [Google Scholar]
  6. Fan S. T., Lai E. C., Lo C. M., Ng I. O., Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995 Feb;130(2):198–203. doi: 10.1001/archsurg.1995.01430020088017. [DOI] [PubMed] [Google Scholar]
  7. Knodell R. G., Ishak K. G., Black W. C., Chen T. S., Craig R., Kaplowitz N., Kiernan T. W., Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981 Sep-Oct;1(5):431–435. doi: 10.1002/hep.1840010511. [DOI] [PubMed] [Google Scholar]
  8. Matsumata T., Higashi H., Shimada M., Adachi E., Shirabe K., Sugimachi K. Indications for major hepatectomy in cirrhotic liver. Hepatogastroenterology. 1994 Apr;41(2):165–169. [PubMed] [Google Scholar]
  9. Nagasue N., Kohno H., Chang Y. C., Taniura H., Yamanoi A., Uchida M., Kimoto T., Takemoto Y., Nakamura T., Yukaya H. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg. 1993 Apr;217(4):375–384. doi: 10.1097/00000658-199304000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nagino M., Nimura Y., Kamiya J., Kondo S., Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology. 1996 Aug;200(2):559–563. doi: 10.1148/radiology.200.2.8685357. [DOI] [PubMed] [Google Scholar]
  11. Noun R., Jagot P., Farges O., Sauvanet A., Belghiti J. High preoperative serum alanine transferase levels: effect on the risk of liver resection in Child grade A cirrhotic patients. World J Surg. 1997 May;21(4):390–395. doi: 10.1007/pl00012259. [DOI] [PubMed] [Google Scholar]
  12. Popper H. Aging and the liver. Prog Liver Dis. 1986;8:659–683. [PubMed] [Google Scholar]
  13. Scheuer P. J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991 Nov;13(3):372–374. doi: 10.1016/0168-8278(91)90084-o. [DOI] [PubMed] [Google Scholar]
  14. Shiffman M. L., Hofmann C. M., Thompson E. B., Ferreira-Gonzalez A., Contos M. J., Koshy A., Luketic V. A., Sanyal A. J., Mills A. S., Garrett C. T. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C. Hepatology. 1997 Sep;26(3):780–785. doi: 10.1002/hep.510260335. [DOI] [PubMed] [Google Scholar]
  15. Takenaka K., Shimada M., Higashi H., Adachi E., Nishizaki T., Yanaga K., Matsumata T., Ikeda T., Sugimachi K. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg. 1994 Aug;129(8):846–850. doi: 10.1001/archsurg.1994.01420320072014. [DOI] [PubMed] [Google Scholar]
  16. Tanabe G., Sakamoto M., Akazawa K., Kurita K., Hamanoue M., Ueno S., Kobayashi Y., Mitue S., Ogura Y., Yoshidome N. Intraoperative risk factors associated with hepatic resection. Br J Surg. 1995 Sep;82(9):1262–1265. doi: 10.1002/bjs.1800820935. [DOI] [PubMed] [Google Scholar]
  17. Tsuzuki T., Sugioka A., Ueda M., Iida S., Kanai T., Yoshii H., Nakayasu K. Hepatic resection for hepatocellular carcinoma. Surgery. 1990 May;107(5):511–520. [PubMed] [Google Scholar]
  18. Wu C. C., Ho W. L., Yeh D. C., Huang C. R., Liu T. J., P'eng F. K. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery. 1996 Jul;120(1):34–39. doi: 10.1016/s0039-6060(96)80238-8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES